DOI QR코드

DOI QR Code

The role of myokine(interleukin) and exercise for the prevention of scarcopenia and anti-inflammation

근감소 및 염증 예방을 위한 운동과 인터루킨(IL-interleukin)의 역할

  • 변용현 (단국대학교 스포츠과학대학원) ;
  • 박우영 (단국대학교 스포츠과학대학원)
  • Received : 2018.05.31
  • Accepted : 2018.06.28
  • Published : 2018.06.30

Abstract

The purpose of this study was myokine product and role with physical activity and literature review. There is accumulating epidemiological evidence that a physically active life plays an independent role in the protection against type 2 diabetes, cardiovascular disease, colon cancer, dementia and even depression. And myokine has been regarded an important factor of exercise training and brain growth factor for the prevention of Alzheimier's disease. During exercise the release of anti-inflammatory myokine from contracting muscle controled the metabolic response, and IL-4, IL-6, IL-7, IL-10, and IL-15 controled muscle hypertrophy, myogenesis and angiogenenesis. IL-6 promoted the lipid metabolism through AMPK activation. IL-1Ra, IL-10 and sTNF-R inhibited $TNF-{\alpha}$ as the pro-inflammatory cytokine. IL-15 increased the releasing volume from contracting muscle, and promoted the anabolic factor of muscle growth. IL-7 and IL-8 activated the angiogenesis through the more activation of C-X-C receptor signal transmission.

이 연구의 목적은 신체활동이 마이오카인 발현에 미치는 영향을 보고자 문헌고찰을 하였다. 신체적인 활동은 제2형 당뇨, 심혈관질환, 대장암, 치매 및 우울증과 같은 질환을 예방하는 역할을 하고 있다. 그리고 마이오카인(myokine)은 운동 훈련에 의해 분비되는 호르몬으로 뇌성장이나 알츠하이머 같은 질환 예방에 도움을 준다. 운동수행과정에서 수축하는 근육으로부터 분비되는 항염증 마이오카인의 생성과 대사 조절에 필요한 분비 활성화가 건강증진에 중요한 요인으로 보고 있다. 인체 골격근에서 분비되는 마이오카인 가운데 IL-4, IL-6, IL-7, IL-8, IL-15 등은 근육비대(hypertrophy)와 세포(myogenesis) 및 혈관생성(angiogenesis) 등의 조절에 관여한다. IL-6는 AMPK 활성화로 인한 대사중 지방 산화를 촉진시키는 작용을 하고, IL-1Ra, IL-10 과 sTNF-R 는 염증성 싸이토카인 $TNF-{\alpha}$의 분비를 억제한다. IL-15는 저항 운동시 근수축을 통한 발현량이 증가하어 근육 성장의 중요 합성요인으로 작용한다. 한편 IL-7 및 IL-8도 신호 전달 수용체 C-X-C를 통해 혈관신생을 촉진시킨다.

Keywords

References

  1. A. H. Mokdad, J. S. Marks, D. F. Stroup, J. L. Gerberding, "Actual causes of death in the United States", JAMA. Vol.10, NO.291 pp. 1238-1245, (2004).
  2. H. Bronnum-Hansen, K. Juel, M. Davidsen, J. Sorensen, "Impact of selected risk factors on quality-adjusted life expectancy in Denmark", Scandinavia J Public Health, Vol.35, NO.5 pp. 510-515, (2007). https://doi.org/10.1080/14034940701271908
  3. J. Tuomilehto, J. Lindstrom, J. G. Eriksson, T. T. Valle, H. Hamalainen, P. Ilanne-Parikka, S. Keinanen-Kiukaanniemi, M. Laakso, A, Louheranta, M, Rastas, V, Salminen, M. M. Uusitupa, "Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance", N England J Medicine, Vol.3, No.18 pp. 1343-1350, (2007).
  4. M. Nocon, T. Hiemann, F. Muller-Riemenschneider, F, Thalau, S. Roll, S. N. Willich, "Association of physical activity with all-cause and cardiovascular mortality: a systematic review and metaanalysis", Eur J Cardiovasc Prev Rehabil., Vol.15, NO.3 pp. 239-246, (2008). https://doi.org/10.1097/HJR.0b013e3282f55e09
  5. K. Y. Wolin, Y. Yan. G. A. Colditz, I. M. Lee, "Physical activity and colon cancer prevention: a meta-analysis", Br J Cancer, Vol.24, No.4 pp. 611-616, (2009).
  6. E. M. Monninkhof, S. G. Elias, F. A. Vlems, I. van der Tweel, A. J. Schuit, D. W. Voskuil F. E. van Leeuwen, "Physical activity and breast cancer: a systematic review", Epidemiology, Vol.18, NO.1 pp. 137-157, (2007). https://doi.org/10.1097/01.ede.0000251167.75581.98
  7. S. Rovio, I, Kareholt E. L. Helkala, M. Viitanen, B. Winblad, J. Tuomilehto, H. Soininen, A. Nissinen, M. Kivipelto, "Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease", Lancet Neurology, Vol.4, No.11 pp. 705-711, (2005). https://doi.org/10.1016/S1474-4422(05)70198-8
  8. P. Komulainen, M. Pedersen, T. Hanninen, H. Bruunsgaard, T. A. Lakka, M. Kivipelto, M. Hassinen, T. H. Rauramaa, B. K. Pedersen, R. Rauramaa, "BDNF is a novel marker of cognitive function in ageing women: the DR's EXTRA Study", Neurobiology Learn Mem, Vol.90, NO.4 pp. 596-603, (2008). https://doi.org/10.1016/j.nlm.2008.07.014
  9. R. S. Paffenbarger, I. M. Lee, R. Leung, "Physical activity and personal characteristics associated with depression and suicide in American college men", Acta Psychiatrica Scandinavia, Vol.377, pp. 16-22, (1994).
  10. C. P. Fischer, A. Berntsen, L. B. Perstrup, P. Eskildsen, B. K. Pedersen, "Plasma levels of interleukin-6 and C-reactive protein are associated with physical inactivity independent of obesity", Scandinavia J Med Science Sports, Vol.17, NO.5 pp. 580-587, (2007).
  11. B. K. Pedersen, "IL-6 signalling in exercise and disease". Biochemical Society Trans, Vol.35, pp. 1295-1297, (2007). https://doi.org/10.1042/BST0351295
  12. B. K. Pedersen, "Muscles and their myokines", J Exp Biol, Vol.15, No.214 pp. 337-346, (2011).
  13. B. K. Pedersen, M. A. Febbraio, "Muscle as an endocrine organ: focus on muscle-derived interleukin-6", Physiology Review, Vol.88, pp. 1379-1406, (2008). https://doi.org/10.1152/physrev.90100.2007
  14. A. Steensberg, G. van Hall, T. Osada, M. Sacchetti, B. Saltin, B. Klarlund Pedersen, "Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6", J Physiol, Vol.15, No.529 pp. 237-242, (2000).
  15. J, Henningsen, K. T. Rigbolt, B. Blagoev, B. K. Pedersen, I. Kratchmarova, "Dynamics of the skeletal muscle secretome during myoblast differentiation", Mol cell Proteomics, Vol.9, pp. 2482-2496, (2010). https://doi.org/10.1074/mcp.M110.002113
  16. B. K. Pedersen, "Muscular interleukin-6 and its role as an energy sensor", Medicine Science Sports Exercise, Vol.44, pp. 392-396, (2012). https://doi.org/10.1249/MSS.0b013e31822f94ac
  17. K. Ostrowski, P. Schjerling, B. K. Pedersen, "Physical activity and plasma interleukin-6 in humans: effect of intensity of exercise", European J Applied Physiology, Vol.83, pp. 512-515, (2000). https://doi.org/10.1007/s004210000312
  18. C. P. Fischer, "Interleukin-6 in acute exercise and training: what is the biological relevance?", Exercise Immunology Rev, Vol.12, pp. 6-33, (2006).
  19. C. Keller, A. Steensberg, H. Pilegaard, T. Osada, B. Saltin, B. K. Pedersen, P. Neufer, "Transcriptional activation of the IL-6 gene in human contracting skeletal muscle: influence of muscle glycogen content", FASEB J, Vol.15, pp. 2748-2750, (2001). https://doi.org/10.1096/fj.01-0507fje
  20. D. L. MacIntyre, S. Sorichter, J. Mair, A. Berg, D. C. "McKenzie, Markers of inflammation and myofibrillar proteins following eccentric exercise in humans", Eur J Appl Physiol, Vol.84, pp. 180-186, (2001). https://doi.org/10.1007/s004210170002
  21. D. A. Henson, D. C. Nieman, S. L. Nehlsen-Cannarella, O. R. Fagoaga, M. Shannon, M. R. Bolton, J. M. Davis, C. T. Gaffney, W. J. Kelln, M. D. Austin, J. M. Hjertman, B. K. Schilling, "Influence of carbohydrate on cytokine and phagocytic responses to 2h of rowing". Med Sci Sports Exerc, Vol.32, pp. 1384-1389, (2000). https://doi.org/10.1097/00005768-200008000-00005
  22. B. K. Pedersen, C. P. Fischer, "Beneficial health effects of exercise the role of IL-6 as a myokine. Beneficial health effects of exercise--the role of IL-6 as a myokine", Trends Pharmacology Science, Vol.28, No.4 pp. 152-156, (2007). https://doi.org/10.1016/j.tips.2007.02.002
  23. R. Roubenoff, H. Parise, H. A. Payette, L. W. Abad, R. D'Agostino, P. F. Jacques, P. W. Wilson, C. A. Dinarello, T. B. Harris, "Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: the Framingham Heart Study", Am J Medicine, Vol.115, pp. 429-435, (2003). https://doi.org/10.1016/j.amjmed.2003.05.001
  24. C. Keller, A. Steensberg, A. K. Hansen, C. P. Fischer, P. Plomgaard, B. K. Pedersen, "The effect of exercise, training, and glycogen availability on IL-6 receptor expression in human skeletal muscle", J Applied Physiology, Vol.99, pp. 2075-2079, (2005). https://doi.org/10.1152/japplphysiol.00590.2005
  25. B. K. Pedersen, "Distinguished Lecture: Muscle as an endocrine organ: IL-6 and other myokines", J Appl Physiol, Vol.107, pp. 1006-1014, (2009). https://doi.org/10.1152/japplphysiol.00734.2009
  26. N. A-Shanti, A. Saini, S. H. Faulkner, C. E. Stewart, "Beneficial synergistic interactions of TNF-alpha and IL-6 in C2 skeletal myoblasts-potential cross-talk with IGF system", Growth Factors, Vol.26, pp. 61-73, (2008). https://doi.org/10.1080/08977190802025024
  27. M, Hashizume, N, Hayakawa, M, Suzuki, M. Mihara, "IL-6/sIL-6R trans-signalling, but not TNF-alpha induced angiogenesis in a HUVEC and synovial cell co-culture system", Rheumatology Int, Vol.29, pp. 1449-1454, (2009). https://doi.org/10.1007/s00296-009-0885-8
  28. N. H. Yeo, N. H., J. Woo, K. O. Shin, J. Y. Park, & S. Kang. "The effects of different exercise intensity on myokine and angiogenesis factors", Journal of Sports Medicine and Physical Fitness, Vol. 52, pp. 448-454, (2012).
  29. K. R. Wilund, "Is the anti-inflammatory effect of regular exercise responsible for reduced cardiovascular disease?", Clin Sci (Lond), Vol.112, No.11 pp. 543-555, (2007). https://doi.org/10.1042/CS20060368
  30. B. K. Pedersen, M. Febbraio, "Muscle-derived interleukin-6--a possible link between skeletal muscle, adipose tissue, liver, and brain", Brain Behav Immun, Vol.19, No.5 pp. 371-376, (2005). https://doi.org/10.1016/j.bbi.2005.04.008
  31. B. K. Pedersen, "The anti-inflammatory effect of exercise: its role in diabetes and cardiovascular disease control", Essays Biochem, Vol.42, pp. 105-117, (2006). https://doi.org/10.1042/bse0420105
  32. K. Nelms, A. D. Keegan, J. Zamorano J. J. Ryan, W. E. Paul, "The IL-4 receptor: signaling mechanisms and biologic functions", Annu Rev Immunol, Vol.17, pp. 701-738. (1999). https://doi.org/10.1146/annurev.immunol.17.1.701
  33. W. E. Paul, "Interleukin-4: a prototypic immunoregulatory lymphokine". Blood. Vol.1, No.77 pp. 1859-1870, (1991).
  34. V. Jacquemin, G. S. Butler-Browne, D. Furling, V. Mouly, "IL-13 mediates the recruitment of reserve cells for fusion during IGF-1-induced hypertrophy of human myotubes", J Cell Sci, Vol.15, No.120 pp. 670-681. (2007).
  35. J. W. Lowenthal, B. E. Castle, J. Christiansen, J. Schreurs, D. Rennick, N. Arai, P. Hoy, Y. Takebe, M. Howard, "Expression of high affinity receptors for murine interleukin 4 (BSF-1) on hemopoietic and nonhemopoietic cells", J Immunol. Vol.15, No.140 pp. 456-464, (1998).
  36. J. G. Van Den Berg, J. Aten, J. Chand, M.A. Claessen, N. Dijkink, L. Wijdenes, J. Lakkis, F.G. Weening, "Interleukin-4 and interleukin-13 act on glomerular visceral epithelial cells", J Am Soc Nephrol., Vol.11, No.3 pp. 413-422, (2000).
  37. O. Prokopchuk, Y. Liu, D. Henne-Bruns, M. Kornmann, "Interleukin-4 enhances proliferation of human pancreatic cancer cells: evidence for autocrine and paracrine actions", Br J Cancer, Vol.14, No.92 pp. 921-928, (2005).
  38. V. Horsley, K. M. Jansen, S. T. Mills, G. K. Pavlath, "IL-4 acts as a myoblast recruitment factor during mammalian muscle growth", Cell, Vol. 113, pp. 483-494, (2003). https://doi.org/10.1016/S0092-8674(03)00319-2
  39. M. Schulze, F. Belema-Bedada, A. Technau, T. Braun, "Mesenchymal stem cells are recruited to striated muscle by NFAT/IL-4-mediated cell fusion", Genes Dev, Vol.1, No. 19 pp. 1787-1798, (2005).
  40. Y. Liu, A. Schlumberger, K. Wirth, D. Schmidtbleicher, J. M. Steinacker, "Different effects on human skeletal myosin heavy chain isoform expression: strength vs. combination training", J Appl Physiol, Vol.94, No.6 pp. 2282-2288. (2003). https://doi.org/10.1152/japplphysiol.00830.2002
  41. F. Kadi, P. Schjerling, L. L. Andersen, N. Charifi, J. L. Madsen, L. R. Christensen, J. R. Andersen, "The effects of heavy resistance training and detraining on satellite cells in human skeletal muscles", J Physiol. Vol.1, No.558 pp. 1005-1012, (2004).
  42. F. B. Aiello, J. R. Keller, K. D. Klarmann, G. Dranoff, R. Mazzucchelli, S. K. Durum, "IL-7 induces myelopoiesis and erythropoiesis", J Immunol, Vol.1, No.178 pp. 1553-1563, (2007).
  43. U. von Freeden-Jeffry, P. Vieira, L. A. Lucian, T. McNeil, S. E. Burdach, R. Murray, "Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine", J Exp Med, Vol.181, No.4 pp. 1519-1526, (1995). https://doi.org/10.1084/jem.181.4.1519
  44. C. Kittipatarin, A. R. "Khaled, Interlinking interleukin-7", Cytokine, Vol.39, No.1 pp. 75-83, (2007). https://doi.org/10.1016/j.cyto.2007.07.183
  45. A. L. Hansen, B. H. Johnsen, J. J. Sollers, K. Stenvik, J. F. Thayer, "Heart rate variability and its relation to prefrontal cognitive function: the effects of training and detraining", Eur J Appl Physiol, Vol.93, No.3 pp. 263-272, (2004). https://doi.org/10.1007/s00421-004-1208-0
  46. A, E. Namen, S. Lupton, K. Hjerrild, J. Wignall, D. Y. Mochizuki, A. Schmierer, B. Mosley, C. J. March, D. Urdal, S. Gillis, "Stimulation of B-cell progenitors by cloned murine interleukin-7", Nature, Vol.333, No.6173 pp. 571-573, (1988). https://doi.org/10.1038/333571a0
  47. R. Mazzucchelli, S. K. Durum, "Interleukin-7 receptor expression: intelligent design", Nat Rev Immunol, Vol.7, No.2 pp. 144-154, (2007). https://doi.org/10.1038/nri2023
  48. F. Haugen, F. Norheim, H. Lian, A. J. Wensaas, S. Dueland, O. Berg, A. Funderud, B. S. Skalhegg, T. Raastad, C. A. Drevon, "IL-7 is expressed and secreted by human skeletal muscle cells", Am J Physiol Cell Physiol. Vol. 298, No.4 pp. 807-816. (2010).
  49. M. H. Chan, A. L. Carey, M. J. Watt, M. A. Febbraio, "Cytokine gene expression in human skeletal muscle during concentric contraction: evidence that IL-8, like IL-6, is influenced by glycogen availability", Am J Physiology Regular Integration Comp Physiology, Vol. 287, pp. R322-R327, (2004). https://doi.org/10.1152/ajpregu.00030.2004
  50. L. Frydelund-Larsen, M. Penkowa, T. Akerstrom, A. Zankari, S. Nielsen, B. K. Pedersen, "Exercise induces interleukin-8 receptor (CXCR2) expression in human skeletal muscle", Express Physiology, Vol.92, pp. 233-240, (2007). https://doi.org/10.1113/expphysiol.2006.034769
  51. T. Akerstrom, A. Steensberg, P. Keller, C. Keller, M. Penkowa, B. K. Pedersen, "Exercise induces interleukin-8 expression in human skeletal muscle", J Physiology, Vol.1, No.2 pp. 507-516, (2005).
  52. E. L. Bek M. A. McMillen, P. Scott, L. D. L. D. Angus, G. W. Shaftan, "The effect of diabetes on endothelin, interleukin-8 and vascular endothelial growth factor-mediated angiogenesis in rats", Clinical Science, Vol.103, No.48 pp. 424S-29S, (2002). https://doi.org/10.1042/CS103S424S
  53. D. J. Waugh, C. Wilson, "The interleukin-8 pathway in cancer", Clinical Cancer Research, Vol.1, No.14 pp. 6735-6741, (2008).
  54. A. R. Nielsen, P. Hojman, P. Erikstrup, C. P. Fischer, P. Plomgaard, R. Mounier, O. H. Mortensen, C. Broholm, S. Taudorf, R. Krogh-Madsen, B. Lindegaard, A. M. Petersen, J. Gehl, B. K. Pedersen, "Association between interleukin-15 and obesity: interleukin- 15 as a potential regulator of fat mass", J Clinical Endocrinology Metabolism, Vol.93, pp. 4486-449, (2008). https://doi.org/10.1210/jc.2007-2561
  55. N. Carbo, J. Lopez-Soriano, P. Costelli, B. Alvarez, S. Busquets, F. Baccino, L. S. Quinn, F. J. Lopez-Soriano, J. M. Argiles, "Interleukin-15 mediates reciprocal regulation of adipose and muscle mass: a potential role in body weight control", Biochim Biophysics Acta, Vol.1526, pp. 17-24, (2001). https://doi.org/10.1016/S0304-4165(00)00188-4
  56. A. R. Nielsen, R. Mounier, P. Plomgaard, O. H. Mortensen, M. Penkowa, T. Speerschneider, H. Pilegaard, B. K. Pedersen, "Expression of interleukin-15 in human skeletal muscle effect of exercise and muscle fibre type composition", J Physiology, Vol.584, pp. 305-312, (2007). https://doi.org/10.1113/jphysiol.2007.139618
  57. S. E. G. Riechman, S. M. Balasekaran, R. E, Roth, "Association of interleukin-15 protein and interleukin-15 receptor genetic variation with resistance exercise training responses", Journal of Applied Physiology, Vol.97, No.6 pp. 2214-2219, (2004). https://doi.org/10.1152/japplphysiol.00491.2004
  58. Y. K. Tamura, T. Watanabe, J. Kantani, N. Hayashi, M. Ishida, "Upregulation of circulating IL-15 by treadmill running in healthy individuals: is IL-15 an endocrine mediator of the beneficial effects of endurance exercise?", Endocrine Journal, Vol.58, No.3 pp. 211-215, (2011). https://doi.org/10.1507/endocrj.K10E-400